Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep863 | Clinical case reports - Pituitary/Adrenal | ECE2017

Lymphocytic hypophysitis which underwent surgery despite the absence of compression of nearby structures. A case report

Gonzalez Javier , Diez Alberto , Prieto Alma , Fernandez Marta

Introduction: Lymphocytic hypophysitis is a strange cause of hypopituitarism which can represent a difficult diagnostic and therapeutic challenge.Objectives and methods: Describe the diagnosis, evolution and treatment of a case of lymphocytic hypophysitis in a patient who began with hypopituitarism and a year after the diagnosis had local symptoms. We reviewed the medical history of the patient from the moment the patient contacted with us to the months ...

ea0037gp.14.07 | Diabetes and obesity – Clinical diabetes | ECE2015

Degree of control of type 2 diabetes in Spain according to individualised glycaemic targets

Minambres Inka , Mediavilla Jose Javier , Gonzalez-Segura Diego , Perez Antonio

Our objective was to estimate the distribution of Spanish diabetic patients attending to individualized glycaemic targets recommended by the ADA/EASD consensus with and without considering hypoglycaemia risk. We conducted a cross-sectional study in a Spanish primary care setting between 2011 and 2012. A total of 5382 type 2 diabetic subjects under antihyperglycaemic treatment for at least 3 months prior to inclusion completed a study visit in which clinical data including age,...

ea0056p1188 | Thyroid cancer | ECE2018

Descriptive study about clinical and surgical characteristics of patients with differentiated thyroid cancer in our health area

Gonzalez Javier , Calderon Dulce Maria , Marton David , Al-Ramadan Mubarak , Perez Jose

Introduction, material and methods: Differentiated thyroid cancer is a pretty common reason for consulting in our specialty. In general terms, the prognosis is good in the main histological type but there are many others that can worsen the prognosis. It can determine the kind of surgery from hemithyroidectomy (e.g. microcarcinoma) to no intervention because of its extension at the moment of diagnosis. We have collected the data of our patients with differentiated thyroid canc...

ea0056p1195 | Thyroid cancer | ECE2018

Comparative study about clinical characteristics at the moment of surgery and follow-up depending of histological type in patients with differentiated thyroid cancer in our health area

Gonzalez Javier , Maria Calderon Dulce Alramadan Mubarak , Martin David , Maria Calderon Dulce

Introduction, material and methods: Papillary thyroid cancer is well known to be a tumour with a good prognosis; in spite of that, it usually presents many recurrences that increases its morbidity. Follicular thyroid cancer is less frequent but has a higher rate of hematogenous dissemination and higher mortality than papillary thyroid cancer. We have collected the data of our patients with differentiated thyroid cancer during the period from 2000 to 2015. In this study, we hav...

ea0056p1144 | Thyroid cancer | ECE2018

Changing treatment trends with radioiodine in thyroid carcinoma at the beginning of 21st century in Castilla-La Mancha (Spain)

Delgado Manuel , Sastre Julia , Quiroga Ivan , Gonzalez Javier , Torres Belvis , Aznar Silvia , Alvarez Visitacion , Herranz Sandra , Moreno Jesus , Gomez Paz

Background and objective: The incidence of differentiated thyroid carcinoma (DTC) is increasing worldwide. Radioiodine (RAI) ablation is one of the main elements in the therapy of DTC after surgical removal of the gland. This study aims to compare the use of I131 in a Spanish Cohort of DTC before and after the American Thyroid Association (ATA) 2009 guidelines.Patients and methods: The Cadit-CAM study was designed to evaluate retrospectively characterist...

ea0056p1203 | Thyroid cancer | ECE2018

Comparative study about differences in staging and prognosis in patients affected or not of BRAF V600E mutation

Gonzalez Javier , Calderon Dulce Maria , Alramadan Mubarak , Perez Jose , Martin David , Acedo Raquel , Jimenez Fulgencio , Campos Yolanda

Introduction, material and methods: The BRAF isoform of RAF has been implicated in the pathogenesis of papillary thyroid cancer, but not of benign or follicular neoplasms. Also, BRAF mutations may confer a worse clinical prognosis than for papillary thyroid cancer without the BRAF mutation. Recurrence occurs more frequently when BRAF mutations are present. In addition, BRAF mutations are associated with extrathyroidal invasion, lymph node me...

ea0063p372 | Thyroid 1 | ECE2019

Prognostic factors for lymph node metastases in patients with papillary thyroid microcarcinoma

Sastre Julia , Cruz Gordillo Andrea , Aznar Silvia , Alvarez Visitacion , Torres Belvis , Delgado Manuel , Gonzalez Javier , Quiroga Ivan , Herranz Sandra , Aguirre Miguel

Background and objective: Papillary thyroid microcarcinoma (PTMC) is recognized as a separate entity by the World Health Organization. Biological behaviour and clinical outcomes of PTMC are heterogenous. Presence of lymph node metastases (LNM) in this group of patients increases the risk of recurrence and makes optimal management in PTMC controversial (observation, lobectomy with or without preventive central ipsilateral dissection). The aim of this study was to describe risk ...

ea0037ep678 | Pituitary: basic and neuroendocrinology | ECE2015

Long-term safety, tolerability, and efficacy of extended release somatostatin analogues

Gonzalez Javier , Garcia-Centeno Rogelio , Arnoriaga Maria , Picallo Maria , Ramirez Maria Laura , Andia Victor Manuel , Olmedilla Yoko Lucia , Lopez Aurelio , Monereo Susana

Introduction: The main indications for the somatostatin analogues (SST-A) are acromegalies and/or neuroendocrine tumors. They can increase fecal fats, which could lead to the loss of fat soluble vitamins. There are few published studies showing the effects of the long-term use.Methods: Retrospective study of patients with SST-A indicated from our endocrinology department in the last 10 years. We analysed indications and different epidemiological, clinica...

ea0056gp231 | Thyroid Cancer - Diagnostics & Treatments | ECE2018

Related recurrence factors in a Spanish cohort of differentiated thyroid carcinoma. Cadit-CAM Study

Quiroga Ivan , Sastre Julia , Delgado Manuel , Aznar Silvia , Alvarez Visitacion , Torres Belvis , Gonzalez Javier , Lamas Cristina , Llaro Mary Gaby , del Val Florentino , Calderon Dulce , Lop Jose

Background and objective: Incidence of differentiated thyroid cancer (DTC) is increasing but not its mortality. Knowing recurrence factors is essential to plan its treatment. Recurrence related factors in our area were reviewed and compared with ATA risk stratification system.Patients and Methods: The Cadit-CAM study was designed to evaluate characteristics of patients diagnosed of DTC in Castilla La Mancha, a region in the central part of Spain, during ...

ea0056gp237 | Thyroid Cancer - Translational | ECE2018

Comparison in survival of the seventh and eighth editions of the American Joint Commision on Cancer in a Spanish cohort of differentiated thyroid carcinoma: Cadit-CAM Study

Sastre Julia , Torres Belvis , Aznar Silvia , Alvarez Visitacion , Delgado Manuel , Gonzalez Javier , Quiroga Ivan , Herranz Sandra , Alfaro Jose Joaquin , Aguirre Miguel

Background and objective: The AJCC-TNM system is optimized to predict survival in patients with cancer. Since January 2018, the new eighth edition of this staging system will be used to classify patients diagnosed of differentiated thyroid carcinoma (DTC). This study aims to compare the seventh and eighth editions of the AJCC-TNM system in a Spanish Cohort of DTC.Patients and Methods: The Cadit-CAM study was designed to evaluate characteristics of patien...